Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mucosal Immunol ; 7(5): 1266-77, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24670426

ABSTRACT

T-helper 1 and 17 (Th1/Th17) responses are important in inflammatory bowel disease (IBD), and research indicates that Toll-like receptor 6 (TLR6) stimulation leads to Th17 cell development within the lung. The gastrointestinal tract, like the lung, is a mucosal surface that is exposed to bacterially derived TLR6 ligands. Thus, we looked at the effects of TLR6 stimulation on the expression of Th17-, Th1-, and regulatory T-cell-associated transcription factors; RORγt, T-bet, and Foxp3, respectively; in CD4+ T cells within gut-associated lymphoid tissue (GALT) in vitro and in vivo. Cells from GALT and spleen were stimulated with anti-CD3 and TLR ligands for TLR1/2 and TLR2/6 (Pam3CSK4 and FSL-1, respectively). FSL-1 was more effective than Pam3CSK4 at inducing Th1 and Th17 responses in the GALT while Pam3CSK4 rivaled FSL-1 in the spleen. TLR6 was further explored in vivo using experimental colitis. Tlr6-/- mice were resistant to colitis, and oral FSL-1 led to more severe colitis in wild-type mice. Similar pro-inflammatory reactions were seen in human peripheral blood mononuclear cells, and TLR6 expression was directly correlated with RORC mRNA levels in inflamed intestines of IBD patients. These results demonstrate that TLR6 supports Th1- and Th17-skewed responses in the GALT and might be an important target for the development of new medical interventions in IBD.


Subject(s)
Colitis/prevention & control , Gastrointestinal Tract/immunology , Lymphoid Tissue/immunology , Th1 Cells/immunology , Th17 Cells/immunology , Toll-Like Receptor 6/physiology , Animals , Cells, Cultured , Colitis/physiopathology , Disease Models, Animal , Female , Fluorescent Antibody Technique , Gene Expression Regulation/immunology , Humans , Mice , Mice, Inbred BALB C , Toll-Like Receptor 6/genetics , Transcription Factors/genetics
2.
Br J Cancer ; 95(7): 896-905, 2006 Oct 09.
Article in English | MEDLINE | ID: mdl-16953240

ABSTRACT

Dendritic cells (DC) are professional antigen-presenting cells that play a pivotal role in the induction of immunity. Ex vivo-generated, tumour antigen-loaded mature DC are currently exploited as cancer vaccines in clinical studies. However, antigen loading and maturation of DC directly in vivo would greatly facilitate the application of DC-based vaccines. We formerly showed in murine models that radiofrequency-mediated tumour destruction can provide an antigen source for the in vivo induction of anti-tumour immunity, and we explored the role of DC herein. In this paper we evaluate radiofrequency and cryo ablation for their ability to provide an antigen source for DC and compare this with an ex vivo-loaded DC vaccine. The data obtained with model antigens demonstrate that upon tumour destruction by radiofrequency ablation, up to 7% of the total draining lymph node (LN) DC contained antigen, whereas only few DC from the conventional vaccine reached the LN. Interestingly, following cryo ablation the amount of antigen-loaded DC is almost doubled. Analysis of surface markers revealed that both destruction methods were able to induce DC maturation. Finally, we show that in situ tumour ablation can be efficiently combined with immune modulation by anti-CTLA-4 antibodies or regulatory T-cell depletion. These combination treatments protected mice from the outgrowth of tumour challenges, and led to in vivo enhancement of tumour-specific T-cell numbers, which produced more IFN-gamma upon activation. Therefore, in situ tumour destruction in combination with immune modulation creates a unique, 'in situ DC-vaccine' that is readily applicable in the clinic without prior knowledge of tumour antigens.


Subject(s)
Cancer Vaccines/immunology , Catheter Ablation , Cryosurgery , Dendritic Cells/immunology , Neoplasms, Experimental/therapy , Animals , Antigens, Neoplasm/immunology , Cell Differentiation , Dendritic Cells/cytology , Female , Flow Cytometry , Immunotherapy , Lymph Nodes/immunology , Lymphocyte Depletion , Mice , Mice, Inbred C57BL , Neoplasms, Experimental/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...